Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study
Condition(s):ObesityLast Updated:October 6, 2022Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):ObesityLast Updated:October 6, 2022Not yet recruiting
Condition(s):Morbid ObesityLast Updated:January 8, 2024Completed
Condition(s):ObesityLast Updated:September 5, 2014Unknown status
Condition(s):ObesityLast Updated:August 14, 2023Recruiting
Condition(s):Nonalcoholic Fatty Liver DiseaseLast Updated:May 1, 2023Recruiting
Condition(s):Obesity; Obesity, Morbid; Metabolic Disease; Weight, BodyLast Updated:March 8, 2024Not yet recruiting
Condition(s):Endoscopic Sleeve GastroplastyLast Updated:April 21, 2017Unknown status
Condition(s):Obesity; Endoscopic Sleeve Gastroplasty; Gastric Motility; Gastric Hormones; Microbiota; Quality of LifeLast Updated:February 28, 2024Recruiting
Condition(s):Obesity, Morbid; End Stage Renal Disease; Kidney Transplantation; Endoscopic Sleeve GastroplastyLast Updated:February 28, 2024Recruiting
Condition(s):ObesityLast Updated:March 6, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.